[PHARMA] QoQ TTM Result on 31-Mar-2015 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 5.94%
YoY- 75.51%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 2,189,312 2,136,265 2,113,938 2,126,165 2,122,933 2,063,690 2,002,411 6.11%
PBT 112,722 126,859 126,467 126,033 125,580 120,733 109,249 2.10%
Tax -28,138 -21,695 -26,277 -26,528 -31,355 -41,862 -41,209 -22.40%
NP 84,584 105,164 100,190 99,505 94,225 78,871 68,040 15.56%
-
NP to SH 84,044 104,679 99,663 99,421 93,844 77,960 66,756 16.54%
-
Tax Rate 24.96% 17.10% 20.78% 21.05% 24.97% 34.67% 37.72% -
Total Cost 2,104,728 2,031,101 2,013,748 2,026,660 2,028,708 1,984,819 1,934,371 5.77%
-
Net Worth 529,786 534,373 528,477 528,173 525,351 507,124 502,293 3.60%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 77,704 90,625 88,011 80,234 72,463 57,457 44,519 44.81%
Div Payout % 92.46% 86.57% 88.31% 80.70% 77.22% 73.70% 66.69% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 529,786 534,373 528,477 528,173 525,351 507,124 502,293 3.60%
NOSH 259,064 259,027 259,057 258,908 258,794 258,737 258,914 0.03%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 3.86% 4.92% 4.74% 4.68% 4.44% 3.82% 3.40% -
ROE 15.86% 19.59% 18.86% 18.82% 17.86% 15.37% 13.29% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 845.08 824.73 816.01 821.20 820.32 797.60 773.39 6.07%
EPS 32.44 40.41 38.47 38.40 36.26 30.13 25.78 16.50%
DPS 30.00 35.00 34.00 31.00 28.00 22.20 17.20 44.75%
NAPS 2.045 2.063 2.04 2.04 2.03 1.96 1.94 3.56%
Adjusted Per Share Value based on latest NOSH - 258,908
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 151.90 148.22 146.67 147.52 147.30 143.19 138.94 6.10%
EPS 5.83 7.26 6.92 6.90 6.51 5.41 4.63 16.55%
DPS 5.39 6.29 6.11 5.57 5.03 3.99 3.09 44.75%
NAPS 0.3676 0.3708 0.3667 0.3665 0.3645 0.3519 0.3485 3.61%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 6.36 6.50 7.13 6.00 4.58 4.63 4.61 -
P/RPS 0.75 0.79 0.87 0.73 0.56 0.58 0.60 15.99%
P/EPS 19.60 16.08 18.53 15.62 12.63 15.37 17.88 6.29%
EY 5.10 6.22 5.40 6.40 7.92 6.51 5.59 -5.91%
DY 4.72 5.38 4.77 5.17 6.11 4.79 3.73 16.94%
P/NAPS 3.11 3.15 3.50 2.94 2.26 2.36 2.38 19.46%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 15/02/16 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 -
Price 6.19 6.50 5.65 6.91 5.28 4.45 4.62 -
P/RPS 0.73 0.79 0.69 0.84 0.64 0.56 0.60 13.92%
P/EPS 19.08 16.08 14.69 17.99 14.56 14.77 17.92 4.25%
EY 5.24 6.22 6.81 5.56 6.87 6.77 5.58 -4.09%
DY 4.85 5.38 6.02 4.49 5.30 4.99 3.72 19.28%
P/NAPS 3.03 3.15 2.77 3.39 2.60 2.27 2.38 17.41%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment